Back
Mersana Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
MRSN
Mersana Therapeutics
Last Price:
$0.37
Seasonality Move:
-7.32%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and MRSN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Mersana Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.36 | Buy |
20-day SMA: | 0.36 | Buy |
50-day SMA: | 0.37 | Buy |
200-day SMA: | 1.26 | Sell |
8-day EMA: | 0.36 | Buy |
20-day EMA: | 0.36 | Buy |
50-day EMA: | 0.43 | Sell |
200-day EMA: | 1.19 | Sell |
Mersana Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 53.67 | Buy |
Chaikin Money Flow: | 2481946 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.33 - 0.39) | Buy |
Bollinger Bands (100): | (0.25 - 0.93) | Sell |
Mersana Therapeutics Technical Analysis
May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Mersana Therapeutics Stock
Is Mersana Therapeutics Stock a Buy?
-
Mersana Therapeutics share price is 0.39 while MRSN 8-day simple moving average is 0.36, which is a Buy signal.
-
The stock price of MRSN is 0.39 while Mersana Therapeutics 20-day SMA is 0.36, which makes it a Buy.
-
Mersana Therapeutics 50-day simple moving average is 0.37 while MRSN share price is 0.39, making it a Buy technically.
-
MRSN stock price is 0.39 and Mersana Therapeutics 200-day simple moving average is 1.26, creating a Sell signal.
MRSN Technical Analysis vs Fundamental Analysis
Sell
46
Mersana Therapeutics (MRSN)
is a Sell
Is Mersana Therapeutics a Buy or a Sell?
-
Mersana Therapeutics stock is rated a SellThe current Mersana Therapeutics [MRSN] share price is $0.39. The Score for MRSN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Mersana Therapeutics Stock Info
Market Cap:
48.6M
Price in USD:
0.39
Share Volume:
2.5M
Mersana Therapeutics 52-Week Range
52-Week High:
2.83
52-Week Low:
0.26
Sell
46
Mersana Therapeutics (MRSN)
is a Sell
Mersana Therapeutics Share Price Forecast
-
What is the Mersana Therapeutics stock price today?The Mersana Therapeutics stock price is 0.39 USD today.
-
Will MRSN stock go up or go down?Mersana Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Mersana Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Mersana Therapeutics is overvalued.
Is Mersana Therapeutics Stock a Buy?
-
Mersana Therapeutics share price is 0.39 while MRSN 8-day exponential moving average is 0.36, which is a Buy signal.
-
The stock price of MRSN is 0.39 while Mersana Therapeutics 20-day EMA is 0.36, which makes it a Buy.
-
Mersana Therapeutics 50-day exponential moving average is 0.43 while MRSN share price is 0.39, making it a Sell technically.
-
MRSN stock price is 0.39 and Mersana Therapeutics 200-day simple moving average is 1.19, creating a Sell signal.
Fundamental Analysis of Mersana Therapeutics
Is Mersana Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.01 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Mersana Therapeutics
Should I short Mersana Therapeutics stock?
-
MRSN Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Mersana Therapeutics is a Sell
-
Mersana Therapeutics Relative Strength Index (RSI) is 53.67, which suggest Mersana Therapeutics is overbought
-
The Bollinger Bands (25) for Mersana Therapeutics is (0.33 - 0.39), which suggest Mersana Therapeutics is a Sell
-
The Bollinger Bands (100) for Mersana Therapeutics is (0.25 - 0.93), which suggest Mersana Therapeutics is a Sell
* Mersana Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.